Showing 1 - 20 results of 29 for search 'David Valcarcel', query time: 0.06s Refine Results
  1. 1
    Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

    Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain by María-Eva Mingot-Castellano, Carlos Grande-García, David Valcárcel-Ferreiras, Clara Conill-Cortés, Loreto de Olivar-Oliver

    Published 2017-01-01
    Get full text
    Article
  2. 2
    Ultrasound Evaluation of Onset Core Muscle Activity in Subjects with Non-Specific Lower Back Pain and Without Lower Back Pain: An Observational Case–Control Study

    Ultrasound Evaluation of Onset Core Muscle Activity in Subjects with Non-Specific Lower Back Pain and Without Lower Back Pain: An Observational Case–Control Study by María Cervera-Cano, David Valcárcel-Linares, Samuel Fernández-Carnero, Luis López-González, Irene Lázaro-Navas, Daniel Pecos-Martin

    Published 2024-10-01
    Get full text
    Article
  3. 3
    Effects of usual yoga practice on the diaphragmatic contractility: A cross-sectional controlled study

    Effects of usual yoga practice on the diaphragmatic contractility: A cross-sectional controlled study by Teresa E. Fernández-Pardo, Mercedes Furió-Valverde, María García-Arrabé, David Valcárcel-Linares, Ignacio Mahillo-Fernández, Germán Peces-Barba Romero

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Core Synergies Measured with Ultrasound in Subjects with Chronic Non-Specific Low Back Pain and Healthy Subjects: A Systematic Review

    Core Synergies Measured with Ultrasound in Subjects with Chronic Non-Specific Low Back Pain and Healthy Subjects: A Systematic Review by Maria Cervera-Cano, Luis López-González, David Valcárcel-Linares, Samuel Fernández-Carnero, Alexander Achalandabaso-Ochoa, Verónica Andrés-Sanz, Daniel Pecos-Martín

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Inspiratory muscle strength and function in mechanically ventilated COVID-19 survivors 3 and 6 months after intensive care unit discharge

    Inspiratory muscle strength and function in mechanically ventilated COVID-19 survivors 3 and 6 months after intensive care unit discharge by Maria Natividad Núñez-Seisdedos, David Valcárcel-Linares, María Teresa Gómez-González, Irene Lázaro-Navas, Luís López-González, Daniel Pecos-Martín, Isabel Rodríguez-Costa

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

    Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial by Jose A. Pérez-Simon, Olga López-Villar, Enrique J. Andreu, José Rifón, Sandra Muntion, María Diez Campelo, Fermín M. Sánchez-Guijo, Carmen Martinez, David Valcarcel, Consuelo del Cañizo

    Published 2011-07-01
    Get full text
    Article
  7. 7
    Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

    Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation by Carlos Vallejo, Montserrat Batlle, Lourdes Vázquez, Carlos Solano, Antonia Sampol, Rafael Duarte, Dolores Hernández, Javier López, Montserrat Rovira, Santiago Jiménez, David Valcárcel, Vicente Belloch, Mónica Jiménez, Isidro Jarque

    Published 2014-10-01
    Get full text
    Article
  8. 8
    The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate

    The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclospori... by Jose Antonio Perez-Simón, Rodrigo Martino, Rocío Parody, Mónica Cabrero, Lucía Lopez-Corral, David Valcarcel, Carmen Martinez, Carlos Solano, Lourdes Vazquez, Francisco J. Márquez-Malaver, Jordi Sierra, Dolores Caballero

    Published 2013-04-01
    Get full text
    Article
  9. 9
    P695: SINGLE-CELL MULTIOMICS ANALYSIS OF MYELODYSPLASTIC SYNDROME PREDICTS CLINICAL RESPONSE TO TREATMENT WITH DNA DEMETHYLATION AGENT

    P695: SINGLE-CELL MULTIOMICS ANALYSIS OF MYELODYSPLASTIC SYNDROME PREDICTS CLINICAL RESPONSE TO TREATMENT WITH DNA DEMETHYLATION AGENT by Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, Gerardo Ferrer, Caterina Mata, Elisabetta Mereu, David Valcarcel, Antonieta Molero, Lurdes Zamora, Laura Palomo, Pamela Acha, Ana Manzanares, Francesc Sole, Manel Esteller

    Published 2023-08-01
    Get full text
    Article
  10. 10
    Evaluation of prognostic factors among patients with chronic graft-versus-host disease

    Evaluation of prognostic factors among patients with chronic graft-versus-host disease by Jose A. Pérez-Simón, Gabriel Afram, Rodrigo Martino, Jose L Piñana, Teresa Caballero-Velazquez, Olle Ringden, David Valcarcel, Dolores Caballero, Mats Remberger, Yanira de Paz, Jordi Sierra, Jesús San Miguel, Hans Hagglund

    Published 2012-08-01
    Get full text
    Article
  11. 11
    Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

    Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation by Irene García Cadenas, David Valcarcel, Rodrigo Martino, J. L. Piñana, Pere Barba, Silvana Novelli, Albert Esquirol, Ana Garrido, Silvana Saavedra, Miquel Granell, Carol Moreno, Javier Briones, Salut Brunet, Jorge Sierra

    Published 2014-01-01
    Get full text
    Article
  12. 12
    P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

    P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIP... by Emma Searle, Jim Cavet, Steven Knapper, Ceri Bygrave, Victoria Campbell, Dima El-Sharkawi, Charlotte Pawlyn, Maria Creignou, Harriet S. Walter, David Valcarcel, Marta Hidalgo, Tomasz Knurowski, Karen Clegg, Neil Pegg, Will West, Debbie Haynes, Kris Frese, Tim C. P. Somervaille

    Published 2023-08-01
    Get full text
    Article
  13. 13
    Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group

    Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group by M. Eva Mingot-Castellano, M. Teresa Álvarez Román, Luis Fernando Fernández Fuertes, Tomás José González-López, José María Guinea de Castro, Isidro Jarque, M. Fernanda López-Fernández, Maria Luisa Lozano, Blanca Sánchez González, David Valcárcel Ferreiras, José Ramón González Porras

    Published 2019-01-01
    Get full text
    Article
  14. 14
    Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective... by Anna Sureda, Carme Canals, Reyes Arranz, Dolores Caballero, Josep Maria Ribera, Mats Brune, Jacob Passweg, Rodrigo Martino, David Valcárcel, Joan Besalduch, Rafael Duarte, Angel León, Maria Jesus Pascual, Ana García-Noblejas, Lucia López Corral, Bianca Xicoy, Jordi Sierra, Norbert Schmitz

    Published 2012-02-01
    Get full text
    Article
  15. 15
    P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY

    P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY by Javier DE LA Rubia, Inés Gómez-Seguí, Joan Cid, David Valcárcel, Rosa Goterris, Miguel Fernández Zarzoso, María Eva Mingot-Castellano, Cristina Pascual Izquierdo, Ana Oliva Hernández, Jorge Martínez Nieto, Laura F. Ávila Idrovo, María Liz Paciello Coronel, Luis M. Hernández

    Published 2023-08-01
    Get full text
    Article
  16. 16
    S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3

    S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AG... by Uwe Platzbecker, Valeria Santini, Pierre Fenaux, Mikkael Sekeres, Michael Robert Savona, Yazan Madanat, María Díez Campelo, David Valcárcel, Thomas Illmer, Anna Jonášová, Petra Belohlavkova, Laurie Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Qi Xia, Lixian Peng, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Rami S. Komrokji, Amer M. Zeidan

    Published 2023-08-01
    Get full text
    Article
  17. 17
    S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3

    S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATIN... by Valeria Santini, Uwe Platzbecker, Pierre Fenaux, Mikkael Sekeres, Michael Robert Savona, Yazan Madanat, María Díez Campelo, David Valcárcel, Thomas Illmer, Anna Jonášová, Petra Belohlavkova, Laurie Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Qi Xia, Lixian Peng, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Faye Feller, Amer M. Zeidan, Rami S. Komrokji

    Published 2023-08-01
    Get full text
    Article
  18. 18
    P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS STIMULATING AGENTS

    P732: ANALYSIS OF PATIENT-REPORTED FATIGUE IN IMERGE PH3 TRIAL OF IMETELSTAT VS PLACEBO IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES R/R TO ERYTHROPOIESIS... by Mikkael Sekeres, Valeria Santini, María Díez Campelo, Rami S. Komrokji, Pierre Fenaux, Michael Robert Savona, Yazan Madanat, David Valcárcel, Thomas Illmer, Anna Jonášová, Petra Belohlavkova, Antoine Regnault, Kristin Creel, Nishan Sengupta, Laurie Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Faye Feller, Amer M. Zeidan, Uwe Platzbecker

    Published 2023-08-01
    Get full text
    Article
  19. 19
    Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD

    Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents:... by Laura Vilorio-Marqués, Christelle Castañón Fernández, Elvira Mora, Lorena Gutiérrez, Beatriz Rey Bua, Maria José Jiménez Lorenzo, Marina Díaz Beya, Miriam Vara Pampliega, Antonieta Molero, Joaquín Sánchez-García, Marisa Calabuig, Maria Teresa Cedena, Tzu Chen-Liang, Johana Alejandra Díaz Santa, Irene Padilla, Francisca Hernández, Rosana Díez, Pedro Asensi, Blanca Xicoy, Guillermo Sanz, David Valcárcel, María Diez-Campelo, Teresa Bernal

    Published 2022-09-01
    Get full text
    Article
  20. 20
    S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM THE PHASE 3 COMMANDS STUDY

    S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM... by Matteo Giovanni Della Porta, Uwe Platzbecker, Valeria Santini, Amer M. Zeidan, Pierre Fenaux, Rami S. Komrokji, Jake Shortt, David Valcárcel, Anna Jonášová, Sophie Dimicoli-Salazar, Ing Soo Tiong, Chien-Chin Lin, Jiahui LI, Jennie Zhang, Ana Carolina Giuseppi, Sandra Kreitz, Veronika Pozharskaya, Karen L. Keeperman, Shelonitda Rose, Jeevan K. Shetty, Sheida Hayati, Sadanand Vodala, Andrius Degulys, Stefania Paolini, Thomas Cluzeau, Guillermo Garcia-Manero

    Published 2023-08-01
    Get full text
    Article

Search Tools: